SCHEMBL6850229

SCHEMBL6850229

CN(CCN(CC(N)=O)S(=O)(=O)c1cc(F)c(Oc2ccc(Cl)cc2)c(F)c1)S(=O)(=O)NC(=O)N1CCOCC1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.39
MAPT P10636 1/20 0.39
MMP2 P08253 2/20 0.37
MMP9 P14780 2/20 0.37
LMNA P02545 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
RAB9A P51151 1/20 0.36
ATM Q13315 1/20 0.36
F10 P00742 1/20 0.36
MMP3 P08254 1/20 0.36
POLB P06746 1/20 0.36
MCOLN3 Q8TDD5 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.35
PCNA P12004 1/20 0.34
EPHX2 P34913 2/20 0.34
BMP1 P13497 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6850151 0.92 ALDH1A1 (0.35) ALDH1A1MAPTMMP2LMNASMN1; SMN2
SCHEMBL6864658 0.92 MMP3 (0.46) ALDH1A1MAPTMMP2MMP9LMNA
SCHEMBL328650 0.92 MMP9 (0.36) ALDH1A1MAPTMMP2MMP9
SCHEMBL10066483 0.84 MMP3 (0.41) ALDH1A1MAPTMMP2MMP9SMN1; SMN2
SCHEMBL10067177 0.84 MMP3 (0.44) ALDH1A1MAPTMMP2MMP9RAB9A
SCHEMBL6865124 0.83 MMP3 (0.40) MMP2MMP9MMP3BMP1
SCHEMBL328661 0.82 KMT2A (0.38) ALDH1A1RAB9APOLBL3MBTL1BMP1
SCHEMBL328488 0.81 MMP3 (0.42) ALDH1A1MAPTMMP2MMP9LMNA
SCHEMBL328414 0.81 DAGLA (0.37) ALDH1A1MMP2MMP9SMN1; SMN2POLB
SCHEMBL328548 0.80 DAGLA (0.37) ALDH1A1MAPTSMN1; SMN2POLBL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2428509-A1 Human adam-10 inhibitors Symphony Evolution, Inc. (US) 2012-03-14 EP disclosed
WO-2011011181-A1 PHARMACOLOGICAL CHAPERONES FOR THE TREATMENT OF ALZHEIMER'S DISEASE AMICUS THERAPEUTICS, INC. (US) 2011-01-27 WO disclosed